Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...
Standards is a series explaining various tech protocols, looking at their practical implementation, and where we could find them in devices around us. At the beginning of this year, WhatsApp debuted a ...
Novavax secures a non-exclusive licensing deal with Pfizer, validating Matrix-M's platform value and shifting NVAX toward a technology provider model. NVAX receives $30M upfront, a potential $500M in ...
The team behind the Matrix open standard and real-time communication protocol has announced the release of its second major version, bringing end-to-end encryption to group VoIP, faster loading times, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results